Related Experiment Videos
[Streptokinase in impending heart infarct]
Nederlands Tijdschrift Voor Geneeskunde
|February 18, 1989
Insights
This case study shows streptokinase effectively treats impending myocardial infarction caused by coronary artery thrombus. Both intracoronary and intravenous administration proved beneficial in this patient scenario.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Myocardial infarction (MI) is a leading cause of mortality, often precipitated by intracoronary thrombus formation.
- Early reperfusion therapy is critical in managing acute coronary syndromes to limit myocardial damage.
Observation:
- A patient presented with symptoms of impending myocardial infarction.
- Diagnostic imaging revealed an intracoronary thrombus within a normal left anterior descending artery.
Findings:
- The patient received both intracoronary and intravenous administration of streptokinase.
- This therapeutic approach successfully resolved the intracoronary thrombus and averted myocardial infarction.
Implications:
- This case highlights streptokinase as a viable treatment option for impending myocardial infarction.
- It underscores the importance of timely thrombolytic therapy in specific intracoronary thrombus scenarios.
Abstract:
A patient is described with an impending myocardial infarction due to presence of an intracoronary thrombus in an otherwise normal left anterior descending artery. This case illustrates that intracoronary and intravenous administration of streptokinase can be of value in the treatment of impending myocardial infarction.